Lynne Bauman

Lynne Bauman is an experienced senior executive in the medical and pharmaceutical sectors, currently serving as Senior Vice President at NeoGenomics Laboratories since March 2022. Previously, Lynne held the position of Director of Medical Affairs at Protagonist Therapeutics and served as Director of Clinical Development at Bavarian Nordic, where responsibilities included the development of novel cancer vaccines and collaboration with the National Cancer Institute. Lynne's extensive career also includes roles such as Vice President of Medical Affairs at Synta Pharmaceuticals and various positions at Novacea, Abbott Laboratories, and Ilex/Genzyme, with a strong focus on oncology and medical science liaison functions. Educational background includes a degree from The University of Texas at Dallas.